Listing for Pediatric Donation After Circulatory Death Heart Transplantation Is Associated With Improved Waitlist

Michael A Catalano1,2, Max Shin1,2, Omar Toubat1,2

  • 1Division of Cardiac Surgery University of Pennsylvania Philadelphia PA USA.

Insights

Pediatric heart transplant candidates listed for donation after circulatory death (DCD) hearts alongside donation after brain death (DBD) hearts show improved transplant rates and reduced waitlist mortality. These patients experience shorter wait times and similar survival outcomes compared to those listed for DBD hearts alone.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Organ Donation Science

Background:

  • Donation after circulatory death (DCD) heart procurement expands the donor pool for heart transplantation.
  • The impact of DCD heart utilization on pediatric outcomes remains incompletely understood.
  • This study addresses the need for data on DCD heart transplant outcomes in children.

Purpose of the Study:

  • To compare waitlist survival and transplant outcomes for pediatric heart transplant candidates listed for donation after brain death (DBD) hearts versus those listed for both DBD and DCD hearts.
  • To characterize the utilization of DCD hearts in the pediatric population.
  • To identify factors influencing waitlist outcomes in pediatric heart transplant candidates.

Main Methods:

  • Utilized the United Network for Organ Sharing database for pediatric heart transplant candidates (<18 years) listed between January 2021 and June 2024.
  • Stratified patients based on listing for DBD exclusively versus listing for both DBD and DCD hearts.
  • Employed Fine-Gray and Kaplan-Meier analyses to compare waitlist and posttransplant outcomes.

Main Results:

  • Of 2449 patients, 3.9% were listed for DCD hearts. DCD candidates had higher rates of cardiopulmonary support and were more likely to be status 1A.
  • Among status 1B/2 patients, listing for DCD hearts increased transplant likelihood (aSHR 2.05; P=0.01) with no waitlist deaths.
  • One-year posttransplant survival was comparable between groups.

Conclusions:

  • Pediatric heart transplant candidates status 1B/2 listed for DCD hearts alongside DBD hearts experience shorter waitlist duration and improved transplant rates.
  • Listing for DCD hearts in this cohort is associated with lower waitlist mortality.
  • Posttransplant survival at one year is similar for patients receiving DBD or DCD hearts.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
307
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
907